GLF
EW icon

Groupe la Francaise’s Edwards Lifesciences EW Stock Holding History

Groupe la Francaise’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,939
Closed -$165K – 480
2025
Q4 		$165K Sell
1,939
-708
-27% -$58.1K ﹤0.01% 378
2025
Q3 		$203K Sell
2,647
-16,527
-86% -$1.29M ﹤0.01% 417
2025
Q2 		$1.49M Buy
19,174
+16,834
+719% +$1.26M 0.02% 250
2025
Q1 		$167K Sell
2,340
-364
-13% -$26.1K ﹤0.01% 366
2024
Q4 		$203K Buy
+2,704
New +$189K 0.01% 281

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Groupe la Francaise's EW Position: Q1 2026 in Review

Groupe la Francaise sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 1,939 shares — an estimated $165K sold.

Groupe la Francaise first reported a position in EW in Q4 2024 and held it in 5 quarters. The position peaked at $1.49M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Groupe la Francaise reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Groupe la Francaise sold 1,939 Edwards Lifesciences shares in Q1 2026, an estimated $165K.
  • Groupe la Francaise first reported a position in Edwards Lifesciences in Q4 2024 and held it in 5 quarters.
  • Groupe la Francaise's Edwards Lifesciences position peaked at $1.49M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.